Posez n’importe quelle question sur les cours, conférences, exercices, recherches, actualités, etc. de l’EPFL ou essayez les exemples de questions ci-dessous.
AVERTISSEMENT : Le chatbot Graph n'est pas programmé pour fournir des réponses explicites ou catégoriques à vos questions. Il transforme plutôt vos questions en demandes API qui sont distribuées aux différents services informatiques officiellement administrés par l'EPFL. Son but est uniquement de collecter et de recommander des références pertinentes à des contenus que vous pouvez explorer pour vous aider à répondre à vos questions.
Cell-free systems have emerged as a powerful platform for protein production, characterization, and bottom-up construction of artificial cells, offering direct control over biochemical environments. However, achieving high-throughput and iterative design–build–test cycles requires advanced strategies beyond conventional methods. Microfluidic technologies address these challenges by enabling miniaturization, automation, and exceptional control over reaction conditions. The integration of cell-free systems with microfluidics has unlocked new capabilities by enabling high-throughput assays, long-lived reactions in continuous-flow systems, and the generation of liposome-based artificial cells. This review highlights recent advances at this interface, focusing on microfluidic strategies for protein characterization, gene regulatory studies, and the bottom-up construction of artificial cells exhibiting life-like functions.